Closing HealthTech Deals: How to Survive the 18-Month B2B Sales Cycle

Closing HealthTech Deals: How to Survive the 18-Month B2B Sales Cycle

27 November 2025

For HealthTech startups, the 18-month sales cycle isn’t a worst-case scenario; it’s often the norm. This reality is one of the biggest challenges founders face. You might have the best device or the smartest AI, but until you understand the unique inertia of the B2B healthcare environment, your pipeline will constantly stall.

This piece, part of Thaver’s series on ‘Building a BD Engine’, reflects on how to not just endure, but effectively manage, this lengthy process.

The Two Forces Driving the Long Cycle

Why does it take so long? It boils down to two non-negotiable forces: Risk Aversion and the Consensus Committee.

Why Healthcare Buyers are Risk-averse

  • Patient safety concerns
  • Regulatory and compliance obligations
  • Complex IT environments
  • Need for clinical or operational validation
  • High cost of procurement mistakes

Just to give you an example, a single NHS trust may take 6–9 months to complete DPIA, InfoSec, and integration readiness reviews.

Every stage, from IT integration to security audits (like HIPAA/GDPR checks) to clinical validation, is designed to de-risk the decision. Your job is not to rush this process, but to front-load the risk mitigation. You must provide clear answers, documentation, and validation before they even ask.

(If compliance preparation slows your deals, our BD Strategy & Execution service supports validation and documentation readiness)

The 5 Stakeholders Who Control Every HealthTech Deal

Diagram: The 5 Stakeholders Who Control Every HealthTech Deal

Each requires a distinct, specialised value proposition to sign off. The sales cycle is simply the time it takes for your champion to gather consensus from all five.

Mastering the ‘Middle Game’

Most startups ace the initial pitch (the ‘opening game’) but fail in the ‘middle game’ – the 12 to 15 months between the first demo and the final contract signing.

Why HealthTech Deals Stall

  • No clear owner for pilot outcomes
  • Gaps of 30–60 days between touchpoints
  • Misaligned expectations about data/results
  • Value unclear to Finance or Operations
  • Too many feature-led conversations

Survival in this phase requires a disciplined approach, not just heroic effort:

Checklist for Defining Pilot Success

  • Agree on 2–3 measurable outcomes
  • Set baseline data before the pilot
  • Align each metric to a specific stakeholder (Finance, Ops, Clinicians)
  • Agree how data will be captured and by whom

If the pilot lacks clear, agreed-upon data points, it will yield inconclusive results and die.

Building Pilot Momentum

  • Establish a Predictable Cadence
    Long cycles create momentum traps.

  • Maintain Deal Velocity

      • End every meeting with a clear next step
      • Assign owners for each action
      • Set 30–45 day check-ins
      • Document blockers and track them
      • Share short written summaries after each review

    This keeps the engagement from slipping into months of silence.

  • Sell Outcomes, Not Features
    The Finance department doesn’t care about your new dashboard; they care that your solution reduces staffing costs or prevents a costly medical error.

What Each Stakeholder Actually Wants

  • Finance – Cost reduction, budget predictability

  • Operations – Workflow efficiency, fewer steps

  • IT – Lower maintenance burden, clean integration

  • Clinicians – Saved time, reduced errors

  • Procurement – Lower risk, simplified contracting

Continuously reframe your value in terms of financial or operational outcomes relevant to the stakeholder you are speaking to.

Turning Survival into Scalability

Navigating these complex, multi-year deals requires more than just luck or talented individual salespeople; it requires a repeatable, documented framework.

A Scalable BD Engine Requires

  • Mapping the stakeholder journey
  • Standardising pilot design and metrics
  • Improving multi-stakeholder value messaging
  • Creating repeatable evidence & proofpoints
  • Documenting internal processes and cadence

Startups often struggle to apply the same strategic rigor to sales that they apply to product development.

Developing this structured approach – one that clearly maps the stakeholder journey, manages complex pilots, and maintains momentum – is essential for transforming a promising startup into a sustainable enterprise.

This is the foundation of a Building a BD Engine framework.

If managing this strategic complexity feels like a distraction from your core mission, it may be time to seek external expertise. This is where our BD Strategy & Execution frameworks help teams shorten cycles and establish repeatable commercial motion.

Thaver enables businesses to achieve ambitious growth and market penetration goals by helping them translate strategy into measurable action, streamline execution processes, and ensure effective resource deployment.

Our core offering, Business Development Strategy & Execution, provides the dedicated framework and hands-on support needed to open new markets, secure key accounts, and accelerate your path to sustained commercial success.

Contact us here to discuss your business.

Share this article

Follow us

Subscribe

Get industry insights, news, and exclusive content from Thaver

Latest articles